Combining Fluoxetine and rTMS in Poststroke Motor Recovery: A Placebo-Controlled Double-Blind Randomized Phase 2 Clinical Trial

被引:21
|
作者
Pinto, Camila Bonin [1 ,2 ,3 ]
Morales-Quezada, Leon [1 ,3 ]
de Toledo Piza, Polyana Vulcano [1 ,3 ,6 ]
Zeng, Dian [1 ,3 ]
Saleh Velez, Faddi Ghassan [1 ,3 ,4 ]
Ferreira, Isadora Santos [1 ,3 ]
Lucena, Pedro Henrique [1 ,3 ]
Duarte, Dante [1 ,3 ]
Lopes, Fernanda [1 ,3 ]
El-Hagrassy, Mirret M. [1 ,3 ]
Rizzo, Luiz Vicente [3 ]
Camargo, Erica C. [1 ,5 ]
Lin, David J. [1 ,5 ]
Mazwi, Nicole [1 ,3 ,5 ]
Wang, Qing Mei [1 ,5 ,6 ,7 ]
Black-Schaffer, Randie [1 ,3 ,5 ]
Fregni, Felipe [1 ,3 ,5 ]
机构
[1] Harvard Med Sch, Boston, MA 02115 USA
[2] Univ Sao Paulo, Sao Paulo, Brazil
[3] Harvard Med Sch, Spaulding Rehabil Hosp, Boston, MA 02115 USA
[4] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[5] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA
[6] Albert Einstein Hosp, Sao Paulo, Brazil
[7] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
关键词
stroke; transcranial magnetic stimulation; fluoxetine; motor recovery; recovery of function; cortical excitability; TRANSCRANIAL MAGNETIC STIMULATION; ENDOTHELIAL GROWTH-FACTOR; EVOKED-POTENTIALS; TRANSCALLOSAL INHIBITION; PROGNOSTIC VALUE; STROKE; DEPRESSION; CORTEX; REHABILITATION; EXCITABILITY;
D O I
10.1177/1545968319860483
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background. Although recent evidence has shown a new role of fluoxetine in motor rehabilitation, results are mixed. We conducted a randomized clinical trial to evaluate whether combining repetitive transcranial magnetic stimulation (rTMS) with fluoxetine increases upper limb motor function in stroke. Methods. Twenty-seven hemiparetic patients within 2 years of ischemic stroke were randomized into 3 groups: Combined (active rTMS + fluoxetine), Fluoxetine (sham rTMS + fluoxetine), or Placebo (sham rTMS + placebo fluoxetine). Participants received 18 sessions of 1-Hz rTMS in the unaffected primary motor cortex and 90 days of fluoxetine (20 mg/d). Motor function was assessed using Jebsen-Taylor Hand Function (JTHF) and Fugl-Meyer Assessment (FMA) scales. Corticospinal excitability was assessed with TMS. Results. After adjusting for time since stroke, there was significantly greater improvement in JTHF in the combined rTMS + fluoxetine group (mean improvement: -214.33 seconds) than in the placebo (-177.98 seconds, P = 0.005) and fluoxetine (-50.16 seconds, P < 0.001) groups. The fluoxetine group had less improvement than placebo on both scales (respectively, JTHF: -50.16 vs -117.98 seconds, P = 0.038; and FMA: 6.72 vs 15.55 points, P = 0.039), suggesting that fluoxetine possibly had detrimental effects. The unaffected hemisphere showed decreased intracortical inhibition in the combined and fluoxetine groups, and increased intracortical facilitation in the fluoxetine group. This facilitation was negatively correlated with motor function improvement (FMA, r(2) = -0.398, P = 0.0395). Conclusion. Combined fluoxetine and rTMS treatment leads to better motor function in stroke than fluoxetine alone and placebo. Moreover, fluoxetine leads to smaller improvements than placebo, and fluoxetine's effects on intracortical facilitation suggest a potential diffuse mechanism that may hinder beneficial plasticity on motor recovery.
引用
收藏
页码:643 / 655
页数:13
相关论文
共 50 条
  • [11] Effect of methylphenidate and/or levodopa coupled with physiotherapy on functional and motor recovery after stroke - a randomized, double-blind, placebo-controlled trial
    Lokk, J.
    Roghani, R. Salman
    Delbari, A.
    ACTA NEUROLOGICA SCANDINAVICA, 2011, 123 (04): : 266 - 273
  • [12] A Randomized, Placebo-Controlled, Double-Blind Efficacy Study of Nefiracetam to Treat Poststroke Apathy
    Starkstein, Sergio E.
    Brockman, Simone
    Hatch, Katherine K.
    Bruce, David G.
    Almeida, Osvaldo P.
    Davis, Wendy A.
    Robinson, Robert G.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2016, 25 (05) : 1119 - 1127
  • [13] Fluoxetine for stroke recovery improvement - the double-blind, randomised placebo-controlled FOCUS-Poland trial
    Bembenek, Jan P.
    Niewada, Maciej
    Klysz, Bozena
    Mazur, Anna
    Kurczych, Katarzyna
    Gluszkiewicz, Marcin
    Czlonkowska, Anna
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2020, 54 (06) : 544 - 551
  • [14] Electric Field Navigated 1-Hz rTMS for Poststroke Motor Recovery: The E-FIT Randomized Controlled Trial
    Edwards, Dylan J.
    Liu, Charles Y.
    Dunning, Kari
    Fregni, Felipe
    Laine, Jarmo
    Leiby, Benjamin E.
    Rogers, Lynn M.
    Harvey, Richard L.
    STROKE, 2023, 54 (09) : 2254 - 2264
  • [15] Transcranial Magnetic Stimulation Combined With Physiotherapy in Rehabilitation of Poststroke Hemiparesis: A Randomized, Double-Blind, Placebo-Controlled Study
    Seniow, Joanna
    Bilik, Marta
    Lesniak, Marcin
    Waldowski, Konrad
    Iwanski, Szczepan
    Czlonkowska, Anna
    NEUROREHABILITATION AND NEURAL REPAIR, 2012, 26 (09) : 1072 - 1079
  • [16] Cerebello-Motor Paired Associative Stimulation and Motor Recovery in Stroke: a Randomized, Sham-Controlled, Double-Blind Pilot Trial
    Rosso, Charlotte
    Moulton, Eric, Jr.
    Kemlin, Claire
    Leder, Sara
    Corvol, Jean-Christophe
    Mehdi, Sophien
    Obadia, Mickael A.
    Obadia, Mickael
    Yger, Marion
    Meseguer, Elena
    Perlbarg, Vincent
    Valabregue, Romain
    Magno, Serena
    Lindberg, Pavel
    Meunier, Sabine
    Lamy, Jean-Charles
    NEUROTHERAPEUTICS, 2022, 19 (02) : 491 - 500
  • [17] A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder
    Garakani, Amir
    Martinez, Jose M.
    Marcus, Sue
    Weaver, James
    Rickels, Karl
    Fava, Maurizio
    Hirschowitz, Jack
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (05) : 269 - 275
  • [18] A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression
    Hantsoo, Liisa
    Ward-O'Brien, Deborah
    Czarkowski, Kathryn A.
    Gueorguieva, Ralitza
    Price, Lawrence H.
    Epperson, C. Neill
    PSYCHOPHARMACOLOGY, 2014, 231 (05) : 939 - 948
  • [19] Olanzapine/Fluoxetine Combination in Children and Adolescents With Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Trial
    Detke, Holland C.
    DelBello, Melissa P.
    Landry, John
    Usher, Roland W.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2015, 54 (03) : 217 - 224
  • [20] Role of fluoxetine in pharmacological enhancement of motor functions in stroke patients: A randomized, placebo-controlled, single-blind trial
    Krishnan, Karthickeyan
    Muthuraj, K.
    Nandhini, K.
    Teja, Yalamanchili Dharma
    Reddy, Vikrama Simha
    Raju, Neethu Sara
    Rathinam, Kiran Kumar
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2021, 23